GSK plc
Last · LSE£18.16+0.63 (+3.59%)close · yahoo · 14h ago
Market cap£72.8B4.01B sh
P/E · TTM15.4fwd 9.5 · eps 1.18
Beta0.28vs S&P 500
Div yield3.88%annual · TTM
52w range
£15.92£22.82
Volume7.4Msession
| Revenue | £32.7B |
|---|---|
| Operating income | £7.9B |
| Net income | £5.7B |
| Free cash flow | £6.4B |
| Operating margin | 24.3% |
| Net margin | 17.5% |
| Return on equity | 34.9% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-04-26
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.82
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$1.33
Est. revenue
8.8B
Earnings transcripts
Press & signals
- Satelight
Fantasy M&A: the recipe for a European champion
- Satelight
Biotech deals surge to record as fear of missing out grips Big Pharma
- Satelight
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans